Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non‐alcoholic fatty liver disease and cardiovascular disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|5|533-539

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.5, 2015-05, pp. : 533-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-alcoholic fatty liver disease

By Smith Briohny W.   Adams Leon A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 3, 2011-06 ,pp. : 97-113

Informa Healthcare

Access to resources Recommend Favorite

Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 3, 2018-02 ,pp. : 469-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterogeneity of non‐alcoholic fatty liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2498-2500

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease in Older People

By  

Gerontology, Vol. 55, Iss. 6, 2009-08 ,pp. : 607-613

Karger

Access to resources Recommend Favorite

Paediatric non‐alcoholic fatty liver disease: an overview

By  

OBESITY REVIEWS, Vol. 16, Iss. 5, 2015-05 ,pp. : 393-405

John Wiley & Sons Inc

Access to resources Recommend Favorite